Critical nodes in signalling pathways: insights into insulin action
The DOI matches its Crossref record; 127 of the 129 references it cites were found in a registry or an index.
Abstract
Physiologically important cell-signalling networks are complex, and contain several points of regulation, signal divergence and crosstalk with other signalling cascades. Here, we use the concept of 'critical nodes' to define the important junctions in these pathways and illustrate their unique role using insulin signalling as a model system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In skeletal muscle, insulin binds to the insulin receptor leading to phosphorylation of three key tyrosine molecules on the insulin receptor. Once the insulin receptor has been phosphorylated, insulin receptor substrate (IRS)-1 moves to the cell membrane and becomes phosphorylated on contiguous tyrosine molecules.”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [25]
In the citing paper
“Reduced phosphorylation of the PI3K/Akt pathway is a hallmark of IR in PCOS patients10–12.”
From Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials (2025) · cites this paper as [10]
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [11]
Citations
Cites
2 retracted
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 272
Self-citationRetractedUeki, K., Fruman, D. A., Yballe, C. M., Fasshauer, M., Klein, J., Asano, T., Cantley, L. C., & Kahn, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305602200 · Cited by 208
Self-citationRetractedPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435 · cited 2×
“The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307).”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“For instance, the phosphorylation of Ser307 of IRS1, which is located in the PTB domain, has been correlated with negative regulation of insulin signallin”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 1×
“Recently, the activation of nuclear factor (NF)-κB-mediated pathways also have been shown to inhibit insulin signalling through enhanced serine phosphorylation of IRS1 (Ref”
BackgroundElchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954 · cited 1×
“Also, the p85/p110–PI3K complex binds to Ras, linking two pathways that are normally considered to be distinc”
Background
Cited by
Items 101–200 of 1,013
Barrett, E. J., Eggleston, E. M., Inyard, A. C., Wang, H., Li, G., Chai, W., & Liu, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1313-z · Cited by 323
“This appears to be secondary to alterations early in the insulin signalling cascade, involving the phosphorylation of serine residues of insulin receptor substrates [71].”
BackgroundIRS1-Independent Defects Define Major Nodes of Insulin Resistance
Hoehn, K. L., Hohnen-Behrens, C., Cederberg, A., Wu, L. E., Turner, N., Yuasa, T., Ebina, Y., & James, D. E. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.005 · Cited by 320
“…to modify the activity of IRS, including protein/ protein interactions, Ser/Thr hyperphosphorylation, tyrosine dephosphorylation, targeted degradation, and other posttranslational modifications such as O-linked glycosylation and acetylation (reviewed in Gual et al., 2005; Taniguchi et al., 2006).”
BackgroundLTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes
Li, P., Oh, D. Y., Bandyopadhyay, G., Lagakos, W. S., Talukdar, S., Osborn, O., Johnson, A., Chung, H., Mayoral, R., Maris, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3800 · Cited by 315
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Cooper, S. A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S., & Sowers, J. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00522.2007 · Cited by 317
“Cross-talk from signaling pathways of heterologous receptors, such as the angiotensin II (Ang II) type 1 receptor (AT1R) exert enhancing effects on this growth/remodeling signaling pathways while interfering with the metabolic signaling pathway (186,190,202).”
BackgroundWang, R.-H., Kim, H.-S., Xiao, C., Xu, X., Gavrilova, O., & Deng, C.-X. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46243 · Cited by 314
Kisfalvi, K., Eibl, G., Sinnett-Smith, J., & Rozengurt, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0418 · Cited by 315
“key pathway in insulin/insulin-like growth factor action (14).”
Type 2 Diabetes Mellitus and Hypertension
Lastra, G., Syed, S., Kurukulasuriya, L. R., Manrique, C., & Sowers, J. R. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.005 · Cited by 307
“Insulin also signals through growth/ proliferative signaling pathway, which is mediated by mitogen-activated protein kinase (MAPK) (38,39).”
Regulation of folliculogenesis and the determination of ovulation rate in ruminants
Scaramuzzi, R. J., Baird, D. T., Campbell, B. K., Driancourt, M.-A., Dupont, J., Fortune, J. E., Gilchrist, R. B., Martin, G. B., McNatty, K. P., McNeilly, A. S., et al. (2011) · Reproduction, Fertility and Development · doi:10.1071/rd09161 · Cited by 310
“The effects of insulin on cellular function are mediated by a complex array of intracellular pathways (Taniguchi et al. 2006) with a multitude of phosphatases, intermediary and terminal kinases as well as numerous scaffold and docking proteins that impart hormone- and tissue-specificity on the…”
Background(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305
“Awell-studied example is inhibition by Akt of the forkhead box O-mediated activation of hepatic gluconeogenic genes in the liver (64).”
BackgroundSelective Insulin and Leptin Resistance in Metabolic Disorders
Könner, A. C., & Brüning, J. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.004 · Cited by 303
SREBPs: the crossroads of physiological and pathological lipid homeostasis
Raghow, R., Yellaturu, C., Deng, X., Park, E. A., & Elam, M. B. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.10.009 · Cited by 305
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity
Luk, T., Malam, Z., & Marshall, J. C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807581 · Cited by 302
“Also downstream of the IR are isoforms of Src homology collagen proteins, which are phosphorylated by the tyrosine kinase activity of IR and trigger activation of members of the MAPK family, promoting cell growth and protein synthesis [109, 110].”
BackgroundThe role of mammalian target of rapamycin (mTOR) in insulin signaling
Yoon, M.-S. (2017) · Nutrients · doi:10.3390/nu9111176 · Cited by 300
“The family of insulin receptor substrates (IRSs: IRS-1, IRS-2, IRS-3, and IRS-4) and other substrates (GRB2-associated-binding protein1 (Gab-1), docking protein P62dok, E3 ubiquitin-protein ligase Cbl, adapter protein containing PH and SH2 domain (APS), and SHC-transforming protein (Shc)), mediating the binding of the…”
BackgroundThe lysosome as a command-and-control center for cellular metabolism
Lim, C.-Y., & Zoncu, R. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201607005 · Cited by 295
“JCB • Volume 214 • NumBer 6 • 2016 654 “top-down” manner, as they involve the engagement of a growth factor ligand to its receptor on the cell surface, followed by signal propagation inside the cell (Taniguchi et al., 2006).”
BackgroundDiabetes-induced hyperglycemia impairs male reproductive function: A systematic review
Maresch, C. C., Stute, D. C., Alves, M. G., Oliveira, P. F., de Kretser, D. M., & Linn, T. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx033 · Cited by 294
Solinas, G., Naugler, W., Galimi, F., Lee, M.-S., & Karin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607626103 · Cited by 284
Taniguchi, C. M., Kondo, T., Sajan, M., Luo, J., Bronson, R., Asano, T., Farese, R., Cantley, L. C., & Kahn, C. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.005 · Cited by 279
Self-citationPark, S. W., Zhou, Y., Lee, J., Lu, A., Sun, C., Chung, J., Ueki, K., & Ozcan, U. (2010) · Nature Medicine · doi:10.1038/nm.2099 · Cited by 281
Titchenell, P. M., Quinn, W. J., Lu, M., Chu, Q., Lu, W., Li, C., Chen, H., Monks, B. R., Chen, J., Rabinowitz, J. D., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.022 · Cited by 281
“Insulin signaling in the liver is mediated by the hepatic insulin receptor (IR), which signals through the downstream kinase, protein kinase B/Akt to coordinate hepatic metabolism (Lu et al., 2012; Taniguchi et al., 2006; Wan et al., 2013; Wan et al., 2011).”
Hypoxia decreases insulin signaling pathways in adipocytes.
Regazzetti, C., Peraldi, P., Grémeaux, T., Najem-Lendom, R., Ben-Sahra, I., Cormont, M., Bost, F., Le Marchand-Brustel, Y., Tanti, J.-F., & Giorgetti-Peraldi, S. (2009) · Diabetes · doi:10.2337/db08-0457 · Cited by 281
“They are upstream of two major signaling pathways: the phosphatidylinositol 3-kinase/protein kinase B (PKB) pathway, responsible for most of the metabolic actions of insulin, and the Ras– extracellular signal–related kinase pathway, which regulates gene expression (1).”
Delibegovic, M., Zimmer, D., Kauffman, C., Rak, K., Hong, E.-G., Cho, Y.-R., Kim, J. K., Kahn, B. B., Neel, B. G., & Bence, K. K. (2009) · Diabetes · doi:10.2337/db08-0913 · Cited by 280
“Although the detailed mechanism(s) underlying insulin resistance remain controversial (4–7), there is general agreement that impaired post-IR signaling is involved (8).”
BackgroundPost-transplant diabetes mellitus in patients with solid organ transplants
Jenssen, T., & Hartmann, A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0137-7 · Cited by 278
Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer
Landi, D., Gemignani, F., Naccarati, A., Pardini, B., Vodicka, P., Vodickova, L., Novotny, J., Forsti, A., Hemminki, K., Canzian, F., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm304 · Cited by 278
Awazawa, M., Ueki, K., Inabe, K., Yamauchi, T., Kubota, N., Kaneko, K., Kobayashi, M., Iwane, A., Sasako, T., Okazaki, Y., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.010 · Cited by 277
“Insulin resistance is often caused by decreased levels of its critical signaling molecules, functional modifications of these proteins, or both (Hotamisligil et al., 1996; Taniguchi et al., 2006).”
Insulin signalling mechanisms for triacylglycerol storage
Czech, M. P., Tencerova, M., Pedersen, D. J., & Aouadi, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2869-1 · Cited by 276
“tion (PI3K), phosphatidylinositol 3,4,5-triphosphate generation and Akt activation (see [41, 42] for comprehensive reviews).”
Lee, J. H., Park, A., Oh, K.-J., Lee, S. C., Kim, W. K., & Bae, K.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194924 · Cited by 275
“Akt stimulates translocation of glucose transporter type 4 (GLUT4) translocation to cell membranes, thus allowing glucose to enter the cell [56].”
BackgroundJanus, A., Szahidewicz-Krupska, E., Mazur, G., & Doroszko, A. (2016) · Mediators of Inflammation · doi:10.1155/2016/3634948 · Cited by 271
“This process triggers transformation of inactive GDP-bound Ras into active form of GTP-bound Ras [19].”
Hua, H., Kong, Q., Yin, J., Zhang, J., & Jiang, Y. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00904-3 · Cited by 273
Belfiore, A., & Malaguarnera, R. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0074 · Cited by 272
“Several recent papers address in a comprehensive way the signaling network of insulin and we refer to them for a more thorough description (Barbieri et al. 2003, Taniguchi et al. 2006, Taguchi & White 2008, Cheng et al. 2010).”
BackgroundDissection of the insulin signaling pathway via quantitative phosphoproteomics
Krüger, M., Kratchmarova, I., Blagoev, B., Tseng, Y.-H., Kahn, C. R., & Mann, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711713105 · Cited by 273
“To date, at least 11 substrates of the IR and IGF-1R have been identified in different cellular systems (1).”
BackgroundInfluentialSelf-citationInsulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection
Tsai, S., Clemente-Casares, X., Zhou, A. C., Lei, H., Ahn, J. J., Chan, Y. T., Choi, O., Luck, H., Woo, M., Dunn, S. E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.003 · Cited by 272
Regulation of obesity and insulin resistance by nitric oxide
Sansbury, B. E., & Hill, B. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.016 · Cited by 274
“states are created equal [357].”
Molecular Mechanism of Insulin Resistance in Obesity and Type 2 Diabetes
Choi, K., & Kim, Y.-B. (2010) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2010.25.2.119 · Cited by 269
“IRS3, IRS4, Gab1, and Shc [9,10].”
Yang, Z.-H., Miyahara, H., & Hatanaka, A. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-120 · Cited by 271
“In the liver, insulin suppresses hepatic glucose output by inhibiting gluconeogenesis and stimulating glycogen synthesis [30].”
BackgroundObesity-induced Insulin Resistance and Hyperglycemia: Etiologic Factors and Molecular Mechanisms
Martyn, J. A. J., Kaneki, M., Yasuhara, S., Warner, D. S., & Warner, M. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181799d45 · Cited by 265
“Akt/PKB modulates these transcription factors and coactivators.(10,13,17) Recent studies indicate that the effect of insulin on lipid metabolism in the liver also is mediated by changes in sterol regulatory element–binding protein-1c (SREBP1C).”
BackgroundKoren, S., & Fantus, I. G. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.08.004 · Cited by 262
Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus
Rachdaoui, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051770 · Cited by 265
“Insulin activation of the PI3K/PKB pathway is known to mostly control metabolic functions, while activation of the Raf/Ras/MEK/ERK pathway through IRS and Shc, regulates cell growth and differentiation [53].”
BackgroundAn insulin-like peptide regulates egg maturation and metabolism in the mosquito Aedes aegypti
Brown, M. R., Clark, K. D., Gulia, M., Zhao, Z., Garczynski, S. F., Crim, J. W., Suderman, R. J., & Strand, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800478105 · Cited by 263
Nox4 Acts as a Switch Between Differentiation and Proliferation in Preadipocytes
Schröder, K., Wandzioch, K., Helmcke, I., & Brandes, R. P. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.174219 · Cited by 258
Wnt signaling regulates mitochondrial physiology and insulin sensitivity
Yoon, J. C., Ng, A., Kim, B. H., Bianco, A., Xavier, R. J., & Elledge, S. J. (2010) · Genes & Development · doi:10.1101/gad.1924910 · Cited by 257
Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism
Gomes, P., Fleming Outeiro, T., & Cavadas, C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.001 · Cited by 255
The Src, Syk, and Tec family kinases: Distinct types of molecular switches
Bradshaw, J. M. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.001 · Cited by 256
Diabetes and Alzheimer’s disease crosstalk
Baglietto-Vargas, D., Shi, J., Yaeger, D. M., Ager, R., & LaFerla, F. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.005 · Cited by 256
Obesity, insulin resistance and comorbidities? Mechanisms of association
Castro, A. V. B., Kolka, C. M., Kim, S. P., & Bergman, R. N. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003223 · Cited by 254
“Detailed description of insulin action is out of the scope of this review and has been reviewed elsewhere (34,35).”
BackgroundImmunity as a link between obesity and insulin resistance
Kalupahana, N. S., Moustaid-Moussa, N., & Claycombe, K. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.011 · Cited by 253
Insulin signaling and the regulation of insect diapause
Sim, C., & Denlinger, D. L. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00189 · Cited by 252
A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin
Wong, R. H. F., Chang, I., Hudak, C. S. S., Hyun, S., Kwan, H.-Y., & Sul, H. S. (2009) · Cell · doi:10.1016/j.cell.2008.12.040 · Cited by 252
“, 1999), mainly through insulin activation of the PI3K pathway (Engelman et al., 2006; Taniguchi et al., 2006), to bind the FAS promoter is critical for feeding/insulin response, SREBP-1c itself cannot bind its SRE without being recruited by USF, which is constitutively bound to the 65 E box (Griffin et al.”
Rozengurt, E., Sinnett-Smith, J., & Kisfalvi, K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2229 · Cited by 247
Kubota, N., Kubota, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Mineyama, T., Ogata, H., Tokuyama, K., Ohsugi, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.007 · Cited by 244
“…insulin resistance, dysregulates nutrient homeostasis by promoting hepatic gluconeogenesis, while the suppression of FoxO1 expression has been demonstrated to reverse the effects of insulin resistance and restore glucose tolerance in diabetic mice (Altomonte et al., 2003; Taniguchi et al., 2006).”
BackgroundInfluentialImpaired insulin action in the human brain: causes and metabolic consequences
Heni, M., Kullmann, S., Preissl, H., Fritsche, A., & Häring, H.-U. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.173 · Cited by 245
Pitetti, J.-L., Calvel, P., Zimmermann, C., Conne, B., Papaioannou, M. D., Aubry, F., Cederroth, C. R., Urner, F., Fumel, B., Crausaz, M., et al. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1258 · Cited by 238
“Upon activation, INSR and IGF1R phosphorylate common substrates that activate a network of downstream effectors, including the phosphatidylinositol 3-kinase (PI3K) and the mitogenactivated protein kinase (MAPK) pathways, which are both associated with proliferation, differentiation, and cell survival (22, 23).”
BackgroundImplication of inflammatory signaling pathways in obesity-induced insulin resistance
Tanti, J.-F., Ceppo, F., Jager, J., & Berthou, F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00181 · Cited by 239
“Insulin resistance is characterized by a decrease in insulin signaling mainly in the Insulin Receptor Substrate (IRS)/PI-3-kinase/PKB axis that is responsible for most of the metabolic actions of the hormone (Taniguchi et al., 2006).”
BackgroundSignal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR
Ortega, M. A., Fraile-Martínez, O., Asúnsolo, Á., Buján, J., García-Honduvilla, N., & Coca, S. (2020) · Journal of Oncology · doi:10.1155/2020/9258396 · Cited by 235
“IRS phosphorylation occurs at tyrosine residues, generally through RTK-type receptors, thus inducing a signalling cascade that, in turn, promotes the activation of other pathways such as PI3K/Akt or MAPK (Figure 1) [114, 119].”
BackgroundMechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue
Silva Rosa, S. C., Nayak, N., Caymo, A. M., & Gordon, J. W. (2020) · Physiological Reports · doi:10.14814/phy2.14607 · Cited by 240
“As shown in Figure 2, one signaling pathway involves the translocation of GLUT4 containing storage vesicles (GSVs) to the plasma membrane, which is regulated by Akt2 (DeFronzo & Tripathy, 2009; Taniguchi et al., 2006).”
BackgroundAdiponectin Regulates Bone Mass via Opposite Central and Peripheral Mechanisms through FoxO1
Kajimura, D., Lee, H. W., Riley, K. J., Arteaga-Solis, E., Ferron, M., Zhou, B., Clarke, C. J., Hannun, Y. A., DePinho, R. A., Guo, X. E., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.009 · Cited by 241
“On the other hand, that FoxO1 phosphorylation is often regulated by PI3kinase-dependent events (Taniguchi et al., 2006) led us to test whether adiponectin signaling in osteoblasts rely on signaling events that can be elicited by PI3-kinase-dependent mechanisms.”
Chakraborty, C., Doss, C. G. P., Bandyopadhyay, S., & Agoramoorthy, G. (2014) · WIREs RNA · doi:10.1002/wrna.1240 · Cited by 238
Insulin Resistance in Obesity as the Underlying Cause for the Metabolic Syndrome
Gallagher, E. J., LeRoith, D., & Karnieli, E. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20212 · Cited by 238
FGF, Insulin, and SMAD Signaling Cooperate for Avian Primordial Germ Cell Self-Renewal
Whyte, J., Glover, J. D., Woodcock, M., Brzeszczynska, J., Taylor, L., Sherman, A., Kaiser, P., & McGrew, M. J. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.008 · Cited by 233
“Insulin acts on many intracellular signaling pathways (Taniguchi et al., 2006) and a central downstream target of insulin signaling is the serine/threonine kinase Akt, involved in cell proliferation and survival.”
Hahn, O., Grönke, S., Stubbs, T. M., Ficz, G., Hendrich, O., Krueger, F., Andrews, S., Zhang, Q., Wakelam, M. J., Beyer, A., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1187-1 · Cited by 226
“Shikama A, Shinozaki H, Takeuchi Y, Matsuzaka T, Aita Y, Murayama T, et al. Identification of human ELOVL5 enhancer regions controlled by SREBP.”
BackgroundInfluentialInsulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle
Dupont, J., & Scaramuzzi, R. J. (2016) · Biochemical Journal · doi:10.1042/bcj20160124 · Cited by 231
NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
Marušić, M., Paić, M., Knobloch, M., & Liberati Pršo, A.-M. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/6613827 · Cited by 230
“Investigations also showed that inflammatory cytokines such as TNF-alpha, IL-1 beta, and IL-6 can induce serine phosphorylation of IRS1 through JNK-1, IKKb, S6K, and mTOR and induce insulin resistance [21–24].”
Obesity and cancer pathogenesis
Berger, N. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12416 · Cited by 231
Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia
Sparks, J. D., Sparks, C. E., & Adeli, K. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241463 · Cited by 231
“In response to feeding, there is rapid release of insulin from the pancreas into the portal vein, followed by insulin binding to hepatic insulin receptors (IR), activation of the intrinsic IR tyrosine kinase, and propagation of signaling via tyrosine phosphorylation of IR substrates (IRS).(22) Tyrosine-phosphorylated…”
BackgroundMolecular Mechanisms and Signaling Pathways Involved in Sertoli Cell Proliferation
Meroni, S. B., Galardo, M. N., Rindone, G., Gorga, A., Riera, M. F., & Cigorraga, S. B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00224 · Cited by 229
“Four IRS proteins that initiate intracellular pathways, named IRS1-4, have been identified (54).”
BackgroundInsulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Cells · doi:10.3390/cells10051236 · Cited by 225
Stress, Overeating, and Obesity: Insights from Human Studies and Preclinical Models
Razzoli, M., Pearson, C., Crow, S., & Bartolomucci, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.026 · Cited by 228
Fatty Acid–Regulated Transcription Factors in the Liver
Jump, D. B., Tripathy, S., & Depner, C. M. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161139 · Cited by 228
Structure, function and regulation of mammalian glucose transporters of the SLC2 family
Holman, G. D. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02411-3 · Cited by 225
“1) Early insulin signalling from the insulin receptor tyrosine kinase activation to the downstream serine kinase Akt is now well understood [206].”
BackgroundCellular and molecular mechanisms of endothelial dysfunction in diabetes
Roberts, A. C., & Porter, K. E. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113500680 · Cited by 225
Diabetes, Obesity, and Breast Cancer
Kang, C., LeRoith, D., & Gallagher, E. J. (2018) · Endocrinology · doi:10.1210/en.2018-00574 · Cited by 222
Regulation of insulin receptor function
Youngren, J. F. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6359-9 · Cited by 223
Systems-level interactions between insulin–EGF networks amplify mitogenic signaling
Borisov, N., Aksamitiene, E., Kiyatkin, A., Legewie, S., Berkhout, J., Maiwald, T., Kaimachnikov, N. P., Timmer, J., Hoek, J. B., & Kholodenko, B. N. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.19 · Cited by 222
“networks amplify mitogenic signaling”
BackgroundA decade of progress in adipose tissue macrophage biology
Hill, A. A., Reid Bolus, W., & Hasty, A. H. (2014) · Immunological Reviews · doi:10.1111/imr.12216 · Cited by 222
Yoshizawa, T., Hinoi, E., Jung, D. Y., Kajimura, D., Ferron, M., Seo, J., Graff, J. M., Kim, J. K., & Karsenty, G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39366 · Cited by 221
DAF-16/FoxO in Caenorhabditis elegans and Its Role in Metabolic Remodeling
Zečić, A., & Braeckman, B. P. (2020) · Cells · doi:10.3390/cells9010109 · Cited by 214
“In humans, the p110 catalytic subunit is recruited to the membrane by PI3K adaptor subunits that bind to the phosphotyrosines of the insulin receptor substrate (IRS) scaffold proteins [58].”
BackgroundNutrient regulation of insulin secretion and action
Newsholme, P., Cruzat, V., Arfuso, F., & Keane, K. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0616 · Cited by 218
“While there are three isoforms of Akt, Akt2 is recognised as the most abundant isoform in insulin-sensitive tissues, promoting the translocation of GLUT4 to the cell membrane and, consequently increasing glucose uptake from the blood (Taniguchi et al. 2006).”
BackgroundMechanisms of Activation of Receptor Tyrosine Kinases: Monomers or Dimers
Maruyama, I. (2014) · Cells · doi:10.3390/cells3020304 · Cited by 215
Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance
Luan, B., Zhao, J., Wu, H., Duan, B., Shu, G., Wang, X., Li, D., Jia, W., Kang, J., & Pei, G. (2009) · Nature · doi:10.1038/nature07617 · Cited by 217
Bouzakri, K., Zachrisson, A., Al-Khalili, L., Zhang, B. B., Koistinen, H. A., Krook, A., & Zierath, J. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.008 · Cited by 217
Insulin, insulin receptors, and cancer
Vigneri, R., Goldfine, I. D., & Frittitta, L. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0508-7 · Cited by 216
“Activated ERK1/2 phosphorylates cytosolic proteins that can translocate to the nucleus, where they regulate gene expression and cell growth [1, 3] (Fig.”
BackgroundChandel, N. S. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040568 · Cited by 215
MicroRNAs and Metabolism Crosstalk in Energy Homeostasis
Dumortier, O., Hinault, C., & Van Obberghen, E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.004 · Cited by 214
Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK
Breen, D. M., Sanli, T., Giacca, A., & Tsiani, E. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.104 · Cited by 213
Gao, D., Madi, M., Ding, C., Fok, M., Steele, T., Ford, C., Hunter, L., & Bing, C. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2013 · Cited by 213
Insulin Regulates Adipocyte Lipolysis via an Akt-Independent Signaling Pathway
Choi, S. M., Tucker, D. F., Gross, D. N., Easton, R. M., DiPilato, L. M., Dean, A. S., Monks, B. R., & Birnbaum, M. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00797-10 · Cited by 211
Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
Bhatnagar, S., Damron, H. A., & Hillgartner, F. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808818200 · Cited by 209
Jiao, Y., Wang, X., Jiang, X., Kong, F., Wang, S., & Yan, C. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.02.003 · Cited by 208
Genome sequences of wild and domestic bactrian camels
The Bactrian Camels Genome Sequencing and Analysis Consortium, Jirimutu, Wang, Z., Ding, G., Chen, G., Sun, Y., Sun, Z., Zhang, H., Wang, L., Hasi, S., et al. (2012) · Nature Communications · doi:10.1038/ncomms2192 · Cited by 206
The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders
Szymczak-Pajor, I., Drzewoski, J., & Śliwińska, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186644 · Cited by 201
“Insulin-initiated elevated level of PIP3 activates serine-threonine kinase phosphoinositide-dependent protein kinase-1 (PDK1) causing both phosphorylation and activation of PKC ζ/λ and protein kinase B also called Akt.”
BackgroundInfluentialArruda, A. P., Milanski, M., Coope, A., Torsoni, A. S., Ropelle, E., Carvalho, D. P., Carvalheira, J. B., & Velloso, L. A. (2011) · Endocrinology · doi:10.1210/en.2010-0659 · Cited by 203
PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy
Thauvin-Robinet, C., Auclair, M., Duplomb, L., Caron-Debarle, M., Avila, M., St-Onge, J., Le Merrer, M., Le Luyer, B., Héron, D., Mathieu-Dramard, M., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.019 · Cited by 202
Lees, E. K., Król, E., Grant, L., Shearer, K., Wyse, C., Moncur, E., Bykowska, A. S., Mody, N., Gettys, T. W., & Delibegovic, M. (2014) · Aging Cell · doi:10.1111/acel.12238 · Cited by 202
“Akt also stimulates the mechanistic target of rapamycin complex 1 (mTORC1), which activates 4E binding protein 1 (4E-BP1) and p70 ribosomal S6 kinase (p70S6K). p70S6K phosphorylates ribosomal protein S6 (S6) to promote protein synthesis (Taniguchi et al., 2006).”
BackgroundInfluentialKoh, H.-J., Arnolds, D. E., Fujii, N., Tran, T. T., Rogers, M. J., Jessen, N., Li, Y., Liew, C. W., Ho, R. C., Hirshman, M. F., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00979-06 · Cited by 202
“The protein kinase Akt functions both in the control of cell proliferation and as a critical node in insulin signaling, appearing to mediate most of the metabolic effects of insulin (44).”
BackgroundSelf-citationVascular and Metabolic Implications of Novel Targeted Cancer Therapies
Li, W., Croce, K., Steensma, D. P., McDermott, D. F., Ben-Yehuda, O., & Moslehi, J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.025 · Cited by 201
“The PI3K/AKT/mTOR pathway can modulate the insulin-signaling pathway (93).”
BackgroundAngiotensin II and the development of insulin resistance: Implications for diabetes
Olivares-Reyes, J. A., Arellano-Plancarte, A., & Castillo-Hernandez, J. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.011 · Cited by 202
Nedd4 Controls Animal Growth by Regulating IGF-1 Signaling
Cao, X. R., Lill, N. L., Boase, N., Shi, P. P., Croucher, D. R., Shan, H., Qu, J., Sweezer, E. M., Place, T., Kirby, P. A., et al. (2008) · Science Signaling · doi:10.1126/scisignal.1160940 · Cited by 201
Defining the underlying defect in insulin action in type 2 diabetes
Batista, T. M., Haider, N., & Kahn, C. R. (2021) · Diabetologia · doi:10.1007/s00125-021-05415-5 · Cited by 195
Self-citationSirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction
Schenk, S., McCurdy, C. E., Philp, A., Chen, M. Z., Holliday, M. J., Bandyopadhyay, G. K., Osborn, O., Baar, K., & Olefsky, J. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58554 · Cited by 197
Mutations in PIK3R1 Cause SHORT Syndrome
Dyment, D. A., Smith, A. C., Alcantara, D., Schwartzentruber, J. A., Basel-Vanagaite, L., Curry, C. J., Temple, I. K., Reardon, W., Mansour, S., Haq, M. R., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.06.005 · Cited by 195
Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells
Xu, X. Q., Graichen, R., Soo, S. Y., Balakrishnan, T., Bte Rahmat, S. N., Sieh, S., Tham, S. C., Freund, C., Moore, J., Mummery, C., et al. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00284.x · Cited by 196
“Insulin can also bind and activate the highly related insulin-growth factor-1 receptor (Adams et al., 2000; Taniguchi et al., 2006).”
Background
Metadata
- Authors
- Taniguchi, C. M., Emanuelli, B., & Kahn, C. R.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Kahn, C. Ronald
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-02-01
- Volume
- 7
- Issue
- 2
- Pages
- 85-96
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1998493448
- Cited by
- 2,760
- References
- 129
- Citations by year
- 2026: 87 · 2025: 91 · 2024: 97 · 2023: 96 · 2022: 149 · 2021: 144 · 2020: 147 · 2019: 118 · 2018: 156 · 2017: 136 · 2016: 148 · 2015: 177 · 2014: 188 · 2013: 189 · 2012: 181
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- Diabetes Research Center
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK031036)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- critical nodes, insulin signaling, signaling networks, signaling crosstalk, signal divergence, insulin resistance, insulin action
- MeSH terms
- Animals, Humans, Insulin, Receptor, Insulin, Signal Transduction, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.